drugset / Trial / NCT02646904

Nebulized Beclometasone Dipropionate Improves Nasal Patency in Children With Allergic Rhinitis

NCT02646904

Phase 4 Completed 68 enrolled Stefania La Grutta, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine in children with persistent AR the effect of the topically applied beclomethasone in comparison with cetirizine on nasal patency evaluated by acoustic rhinometry and subjective nasal symptoms.

Timeline

Start
2016-05
Primary completion
2017-06
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator CERCHIO Unknown 5 mg
Comparator CERCHIO Unknown 10 mg
Subject beclomethasone dipropionate Other / unclassified 100 ug Intranasal

Indications